We're developing a broad portfolio that has the potential to meaningfully improve millions of lives.
Vaxxine Program (Target)
Stage of Development
Parkinson’s, DLB, MSA
Vaxxinity is committed to developing safe and effective immunotherapeutic vaccines, with a goal of providing our next generation products as soon as possible through efficient product development. At this time, Vaxxinity’s investigational products can only be accessed through participation in a clinical trial. For detailed information on our ongoing clinical trials, please CLICK HERE. Vaxxinity does not currently offer an expanded access program.